Navigation Links
Halozyme Therapeutics Reports 2008 First Quarter Financial Results
Date:5/8/2008

- Pipeline Update Conference Call and Webcast on May 9 at 8:00 a.m. PDT -

SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today reported financial results for the three months ended March 31, 2008.

"This year is off to a solid start as we significantly advanced both our partnered and proprietary programs in the first quarter of 2008," said Jonathan Lim, MD, Halozyme's President and CEO. "In addition, we are pleased to disclose that insulin is the target of our "Cheetah" program. We will be presenting Phase I clinical data at the upcoming American Diabetes Association meeting next month in San Francisco. This study was designed to identify whether injections of mealtime insulins formulated with PH20 could create a more rapid blood glucose control compared to the best insulin products available today indicated for diabetes. The existing global market for insulin and insulin analogs is estimated at $10 billion. A faster acting insulin may allow physicians and patients tighter glycemic control that more closely mimics natural physiologic human insulin levels and potentially result in a reduction of long-term complications."

Recent Scientific Achievements

-- Preliminary results of a Phase I/II clinical trial demonstrated that

subcutaneous infusion (under the skin) of GAMMAGARD LIQUID [Immune

Globulin Intravenous (Human)] (IGIV) with Enhanze(TM) Technology

enabled administration of a full monthly dose of immune globulin via a

single subcutaneous site to patients with primary immunodeficiency

(PID). Baxter presented the res
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
2. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
3. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
4. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
5. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
6. Halozyme Therapeutics Amends Stockholder Rights Plan
7. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
8. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
9. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
10. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
11. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...ected to aid drug discovery by allowing for the ra...gle reaction, ST. LOUIS, Oct. 7 /PRNewswire-First...o announce that it has signed an exclusive licensi...bana-Champaign allowing,Sigma-Aldrich to offer res...ogates for use in Suzuki-Miyaura coupling to resea...
(Date:10/7/2008)...s to focus on new patient data supporting the Ross...ynerGraft processed human heart .../- CryoLife, Inc. (NYSE: C...ocessing company, announced today,that cardiovascu...e in the,Ross Summit 2008, a two-day surgical cong...
(Date:10/7/2008)...Institutes of Health, The Infectious Disease Resea...Launch and Board of Advisors, SEATTLE, Oct. 7 /PR...,Initiative today announced its first acquisition ...osis (TB) drug candidates. Agreements were reached...nd the Microbial Chemistry,Research Foundation (MC...
(Date:10/7/2008)... Oct. 7 /- BioEnergy International, L...r and manufacturer of,next-generation, renewable b...f Norman R. Augustine to its Board of Advisors eff...f distinguished leadership and innovation,at the h...g in his role as,Chairman and Chief Executive Offi...
Breaking Biology Technology:Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 2Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 2CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 2Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 3Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 5BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3
... computing performance were developed at the comp...ents at the University of Wisconsin-Madison. , ,In...rmance, distributed database architectures, grid a... touted by Professor Guri Sohi, department chair, ...isons monthly meeting. , ,Pentium-class microproc...
...unced on Tuesday that they have continued their tr... introduction of their newest model in the Illumin...e new lights which offer 50 percent more light at ...fixture, able to reach heights between 14 and 100 ...ercial and industrial facilities, such as warehous...
...d company that makes industrial control systems, h...ware , a privately owned Massachusetts company. , ...ckwell,s call-center solution, known as FirstPoint...ale will allow Rockwell to focus on its industrial...ny,s chief executive, said in a statement. , ,Con...
...tion Networks Corp. has released a new version of...nd text messages to be sent over an intranet to co...new version, InformaCast 3.1 , adds features such...-IP phones, and add predefined text messages to vo...Manager, Berbee said. , ,It also allows messages t...
Other Biology Technology:UW computer scientists tout achievements and explain industry shortcomings 2UW computer scientists tout achievements and explain industry shortcomings 3
(Date:10/7/2008)...e might be the secret weapon for winning the war a...son University have designed and tested a nutritio...each students how to evaluate their dietary intake...Department of Agriculture,s MyPyramid.gov for Ki...at allows kids to win by fueling their rocket with...
(Date:10/6/2008)... Office Replaces Passwords with Fingerprint ...HANHASSEN, Minn. and WALL, N.J., Oct. 6 /PRNewswir...lletin Board: BKYI), a leader in,finger-based biom...lutions,and its partner Sig-Tec, a leader in iden...ounced today the successful deployment of a,finger...
(Date:10/6/2008)... drug can prevent -- and even reverse -- potential... progeria, a rare genetic disorder that causes the...onal Institutes of Health (NIH) researchers report... early online edition of the Proceedings of the N...s S. Collins, M.D., Ph.D., of the National Human G...
(Date:10/6/2008)..., A study by biologists at Washington University i...ulation is in an area, the less chance humans have...,s hear it for the birds. , "The bottom line is t...yard, you have much lower risk of contracting West... in biology in Arts & Sciences at Washington Unive...
Breaking Biology News(10 mins):'Color My Pyramid' nutrition education program battles obesity in DC schools 2Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency 2Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency 3Sig-Tec(R) and BIO-key(R) Deliver Advanced Biometric Security Solution to Ohio County Law Enforcement Agency 4Anti-cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder 2Anti-cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder 3Study: Bird diversity lessens human exposure to West Nile Virus 2Carbon dioxide scrubber captures greenhouse gases 5117 1Carbon dioxide scrubber captures greenhouse gases 5117 2Carbon dioxide scrubber captures greenhouse gases 5117 3Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices 7967 1Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices 7967 2Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices 7967 3Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices 7967 4Commercial aquatic plants offer cost effective method for treating wastewater 5113 1Commercial aquatic plants offer cost effective method for treating wastewater 5113 2Experts to discuss global water crisis 5109 1Experts to discuss global water crisis 5109 2
...k to the amazing repertoire of carbon nanotubes --...cells. , Nanotubes, tiny hollow carbon filaments a...ir, are already famed as one of the most versatile...ong as steel and one-sixth as dense, able to condu... for silicon in semiconductor chips, carbon nanotu...
...an that 2006 is shaping up as the worst year for C...cording to Art Shapiro, professor of evolution and...ast spring, when millions of painted lady butterfl... species have seen steep declines in recent years ... "It has been the worst spring for butterflies of ...
...ed in Chinese medicine to treat the symptoms of ty...reverses some of the pancreatic dysfunctions that ...ne 7, 2006, Cell Metabolism. The chemical therefor...tes therapies, they said. , Such a drug could offe...available therapy for diabetes actually targets th...
...lar disease and cancer in Asia where people smoke ...ption of tea, particularly green tea, according to...dicine researcher. , "We do not yet have a full ex... the very low incidence of both heart disease and ...tes is greater than in most other countries," said...
Other Biology News:Nanotubes used for first time to send signals to nerve cells 2Where have all the butterflies gone? 2Gardenia fruit compound starting point for diabetes therapy 2Green tea and the 'Asian Paradox' 2
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface.
Antibeta-lactoglobulin monoclonal antibody(CD-2)
MAb to Vasopressin Preservative: NaN3
...α, clone 8G8/5 GenBank Accession Number : N...lpha/gamma fusion protein corresponding to residue...0 of human AP-2γ Formulation: 0.1M Tris-glyc... the addition of glycerol to 30% Quality Assurance...
Biology Products: